Zoetis (ZTS) Change in Receivables (2014 - 2026)
Zoetis (ZTS) reported Change in Receivables of $106.0 million for Q1 2026, up 130.43% year-over-year from $46.0 million in Q1 2025, and up 103.85% quarter-over-quarter from $52.0 million in Q4 2025.
Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Change in Receivables data on file, last reported at $106.0 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $106.0 million, up 130.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $296.0 million (up 211.58% YoY), and the FY2025 annual result was $236.0 million, up 286.89% from the prior year.
- Change in Receivables grew to $106.0 million in Q1 2026 per ZTS's latest filing, from $52.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $148.0 million in Q2 2025 and troughed at -$73.0 million in Q4 2024.
- A 5-year average of $37.8 million and a median of $46.0 million in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables tumbled 933.33% in 2022, then surged 283.33% in 2025.
- A 5-year view of Change in Receivables shows it stood at $17.0 million in 2022, then surged by 182.35% to $48.0 million in 2023, then plunged by 252.08% to -$73.0 million in 2024, then soared by 171.23% to $52.0 million in 2025, then soared by 103.85% to $106.0 million in 2026.
- Business Quant data shows ZTS's Change in Receivables at $106.0 million in Q1 2026, $52.0 million in Q4 2025, and -$10.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 20.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 48.00 Mn |
| Dec 31, 2023 | 48.00 Mn |